Our results suggested that a combination of AZD5363 and AZD8055 treatment associates with an enhanced accumulation of nuclear FOXO3a leading to Bim induction and promotes programmed cell death in p53 mutated HCC cells. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.